190 related articles for article (PubMed ID: 24532043)
1. Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Gattazzo C; Martini V; Frezzato F; Trimarco V; Tibaldi E; Castelli M; Facco M; Zonta F; Brunati AM; Zambello R; Semenzato G; Trentin L
Haematologica; 2014 Jun; 99(6):1069-77. PubMed ID: 24532043
[TBL] [Abstract][Full Text] [Related]
2. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.
Frezzato F; Gattazzo C; Martini V; Trimarco V; Teramo A; Carraro S; Cabrelle A; Ave E; Facco M; Zambello R; Tibaldi E; Brunati AM; Semenzato G; Trentin L
PLoS One; 2012; 7(6):e39902. PubMed ID: 22768161
[TBL] [Abstract][Full Text] [Related]
3. Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Martini V; Gattazzo C; Frezzato F; Trimarco V; Pizzi M; Chiodin G; Severin F; Scomazzon E; Guzzardo V; Saraggi D; Raggi F; Martinello L; Facco M; Visentin A; Piazza F; Brunati AM; Semenzato G; Trentin L
Br J Haematol; 2017 Jul; 178(1):81-93. PubMed ID: 28419476
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
[TBL] [Abstract][Full Text] [Related]
5. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
6. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Severin F; Mouawad N; Ruggeri E; Visentin A; Martinello L; Pagnin E; Trimarco V; Pravato S; Angotzi F; Facco M; Trentin L; Frezzato F
Br J Haematol; 2023 Oct; 203(2):224-236. PubMed ID: 37495265
[TBL] [Abstract][Full Text] [Related]
8. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
9. CD1d expression as a prognostic marker for chronic lymphocytic leukemia.
Anastasiadis A; Kotsianidis I; Papadopoulos V; Spanoudakis E; Margaritis D; Christoforidou A; Gouliamtzi S; Tsatalas C
Leuk Lymphoma; 2014 Feb; 55(2):320-5. PubMed ID: 23668820
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
[TBL] [Abstract][Full Text] [Related]
11. Cortactin Expression in Hematopoietic Cells: Implications for Hematological Malignancies.
Castellanos-Martínez R; Jiménez-Camacho KE; Schnoor M
Am J Pathol; 2020 May; 190(5):958-967. PubMed ID: 32084363
[TBL] [Abstract][Full Text] [Related]
12. High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
Butrym A; Majewski M; Dzietczenia J; Kuliczkowski K; Mazur G
Leuk Res; 2012 Jul; 36(7):876-80. PubMed ID: 22333038
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
14. Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia.
Trentin L; Frasson M; Donella-Deana A; Frezzato F; Pagano MA; Tibaldi E; Gattazzo C; Zambello R; Semenzato G; Brunati AM
Blood; 2008 Dec; 112(12):4665-74. PubMed ID: 18768392
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
16. Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib.
Motiwala T; Datta J; Kutay H; Roy S; Jacob ST
J Cell Biochem; 2010 Jul; 110(4):846-56. PubMed ID: 20564182
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
18. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
